Paul R Bergstresser, MD - Dermatology in Dallas, TX

Paul R Bergstresser, MD is a Dermatology physician based in Dallas, Texas. Paul R Bergstresser is licensed to practice in Texas (license number E6993) and his current practice location is 5323 Harry Hines Blvd, Dallas, Texas. He can be reached at his office (for appointments etc.) via phone at (214) 645-2400.

NPI number for Paul R Bergstresser is 1184693632 and his current mailing address is Po Box 845347, Dallas, Texas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1184693632.

Contact Information

Paul R Bergstresser, MD
5323 Harry Hines Blvd,
Dallas, TX 75390-7208
(214) 645-2400
Not Available



Physician's Profile

Full NamePaul R Bergstresser
GenderMale
SpecialityDermatology
Location5323 Harry Hines Blvd, Dallas, Texas
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1184693632
  • Provider Enumeration Date: 03/16/2006
  • Last Update Date: 03/28/2008

Medical Identifiers

Medical identifiers for Paul R Bergstresser such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184693632NPI-NPPES
119050602MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology E6993 (Texas)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paul R Bergstresser is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Paul R Bergstresser, MD
Po Box 845347,
Dallas, TX 75284-5347

Ph: (214) 645-2400
Paul R Bergstresser, MD
5323 Harry Hines Blvd,
Dallas, TX 75390-7208

Ph: (214) 645-2400

News Archive

Health Canada approves Merus Labs' advanced wound care product, Collexa

Merus Labs International Inc. is pleased to announce that Health Canada has approved its advanced wound care product Collexa. Collexa is exclusively licensed to Merus Labs by Innocoll for sales and distribution in Canada.

Incorporating laughter into exercise program could provide health benefits to older adults

Incorporating laughter into a physical activity program that is focused on strength, balance and flexibility could improve older adults' mental health, aerobic endurance and confidence in their ability to exercise, according to a study led by Georgia State University.

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.

IRIN examines new global agricultural strategy report

IRIN examines a new global food security strategy based on a report to be presented on March 28 in France at the first Global Conference on Agricultural Research for Development (GCARD). The article includes details about food insecurity around the world, which has given rise to the need for new methods of providing more food.

Read more News

› Verified 8 days ago


Dermatology Doctors in Dallas, TX

Titilola Sode,
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390
Phone: 214-590-8000    
Dr. Jon Davis Pruett, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 8201 Preston Rd Ste 440, Dallas, TX 75225
Phone: 214-675-3227    
Dr. Daniel D. Witheiler, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1411 N Beckley Ave, Pavilion Iii, Suite 470, Dallas, TX 75203
Phone: 214-941-7546    Fax: 214-941-2442
Dr. Lynne Jeanine Roberts, M.D.
Dermatology
Medicare: Medicare Enrolled
Practice Location: 8144 Walnut Hill Ln, Ste 360, Dallas, TX 75231
Phone: 469-232-9300    Fax: 469-232-9850
Patrick Henry Mcdonough,
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 6162 E Mockingbird Ln, Suite 120, Dallas, TX 75214
Phone: 214-463-8328    
Juliet Gibson,
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 8144 Walnut Hill Ln Ste 1300, Dallas, TX 75231
Phone: 214-420-7070    Fax: 214-420-7380
Dr. Martin Alan Menter, MD
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 3900 Junius St, Suite 145, Dallas, TX 75246
Phone: 972-386-7546    Fax: 972-701-8008

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.